Intervention Review

Ketamine as an adjuvant to opioids for cancer pain

  1. Rae F Bell1,2,*,
  2. Christopher Eccleston3,
  3. Eija A Kalso4

Editorial Group: Cochrane Pain, Palliative and Supportive Care Group

Published Online: 14 NOV 2012

Assessed as up-to-date: 24 MAY 2012

DOI: 10.1002/14651858.CD003351.pub2


How to Cite

Bell RF, Eccleston C, Kalso EA. Ketamine as an adjuvant to opioids for cancer pain. Cochrane Database of Systematic Reviews 2012, Issue 11. Art. No.: CD003351. DOI: 10.1002/14651858.CD003351.pub2.

Author Information

  1. 1

    Haukeland University Hospital, Centre for Pain Management and Palliative Care & Regional Centre for Excellence in Palliative Care, Bergen, Norway

  2. 2

    Haukeland Univeristy Hospital, Regional Centre of Excellence in Palliative Care, Bergen, Norway

  3. 3

    Centre for Pain Research, University of Bath, Cochrane Pain, Palliative and Supportive Care Review Group, Bath, UK

  4. 4

    Helsinki University Central Hospital, Department of Anaesthesia and Intensive Care Medicine, Helsinki, Finland

*Rae F Bell, rae.bell@helse-bergen.no. raeb@frisurf.no.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 14 NOV 2012

SEARCH